← Back to Analyst Consensus 
RXO Hold
RXO, Inc.
Current Price —
Implied Upside —
Analysts 25
30-Day Momentum
▲ 2 upgrades / ▼ 1 downgrades / 3 reiterations from 6 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Oct 6, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Oct 6, 2026 | TD Cowen | upgrade | Sell → Hold | — | 54% |
| Oct 6, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 6, 2026 | JP Morgan | upgrade | Underweight → Neutral | — | 55% |
| Oct 6, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Sep 23, 2026 | Susquehanna | upgrade | Negative → Neutral | — | 56% |
| Sep 9, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 7, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | TD Cowen | maintain | Sell → Sell | — | 54% |
| Aug 7, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | Citizens | upgrade | Market Perform → Market Outperform | — | 46% |
| Aug 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 28, 2026 | TD Cowen | downgrade | Hold → Sell | — | 54% |
| Jul 16, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Jul 15, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 14, 2026 | Susquehanna | maintain | Negative → Negative | — | 56% |
| Jul 14, 2026 | BMO Capital | initiate | — → Outperform | — | 53% |
| Jul 13, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 9, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jun 30, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jun 26, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 15, 2026 | Stifel | upgrade | Hold → Buy | — | 53% |
| May 8, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| May 8, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| May 8, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| May 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 8, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 8, 2026 | Susquehanna | maintain | Negative → Negative | — | 56% |
| May 8, 2026 | Morgan Stanley | downgrade | Overweight → Equal-Weight | — | 54% |
| Apr 22, 2026 | Susquehanna | maintain | Negative → Negative | — | 56% |
| Mar 25, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| Mar 4, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Feb 9, 2026 | Citigroup | maintain | Neutral → Neutral | $18 | 54% |
| Feb 9, 2026 | Truist Securities | maintain | Buy → Buy | $20 | 54% |
| Feb 8, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jan 15, 2026 | Truist Securities | maintain | Buy → Buy | $18 | 54% |
| Jan 9, 2026 | TD Cowen | maintain | Hold → Hold | $14 | 54% |
| Jan 8, 2026 | Citigroup | maintain | Neutral → Neutral | $15 | 54% |
| Jan 8, 2026 | Susquehanna | maintain | Negative → Negative | $11 | 56% |
| Dec 16, 2025 | Stifel | maintain | Hold → Hold | $16 | 53% |
| Nov 14, 2025 | Wolfe Research | upgrade | Underperform → Peer Perform | $0 | 54% |
| Nov 11, 2025 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $19 | 54% |
| Nov 7, 2025 | UBS | maintain | Neutral → Neutral | $15 | 54% |
| Nov 7, 2025 | Truist Securities | maintain | Buy → Buy | $20 | 54% |
| Nov 7, 2025 | Barclays | maintain | Overweight → Overweight | $15 | 53% |
| Nov 7, 2025 | Susquehanna | maintain | Negative → Negative | $10 | 56% |
| Oct 10, 2025 | Stifel | maintain | Hold → Hold | $17 | 53% |
| Oct 9, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $15 | 54% |
| Oct 8, 2025 | JP Morgan | maintain | Underweight → Underweight | $16 | 55% |
Price Target Trend
Apr 26, 2026 Latest: $27.96 Oct 25, 2026
EPS Estimates
+1y $0.65
Lo: $0.45 Hi: $0.87
20 analysts ▲6
0q $0.07
Lo: $0.05 Hi: $0.09
19 analysts ▲5
+1q $0.09
Lo: $0.00 Hi: $0.14
18 analysts ▲1
0y $0.15
Lo: $0.10 Hi: $0.18
19 analysts ▲4
Cross-Platform Signals
No cross-platform signals in the last 90 days